A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke.
about
Neurotransmitter receptors in the life and death of oligodendrocytesGenetics of ischaemic stroke in young adultsMetabolomic analysis of rat brain by high resolution nuclear magnetic resonance spectroscopy of tissue extractsElectroacupuncture preconditioning-induced neuroprotection may be mediated by glutamate transporter type 2.Validation of housekeeping genes for quantitative real-time PCR in in-vivo and in-vitro models of cerebral ischaemia.Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5.Detection of three closely located single nucleotide polymorphisms in the EAAT2 promoter: comparison of single-strand conformational polymorphism (SSCP), pyrosequencing and Sanger sequencing.Isolation of human genomic DNA for genetic analysis from premature neonates: a comparison between newborn dried blood spots, whole blood and umbilical cord tissue.Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache.Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophreniaTransporters for L-glutamate: an update on their molecular pharmacology and pathological involvement.The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.Glutamate mediates platelet activation through the AMPA receptor.Interleukin-6 Receptor Polymorphisms Contribute to the Neurological Status of Korean Patients with Ischemic Stroke.Glutamate transporters in brain ischemia: to modulate or not?Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity.The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis.Neural Stem Cell Transplantation Induces Stroke Recovery by Upregulating Glutamate Transporter GLT-1 in Astrocytes.Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.Genetic dys-regulation of astrocytic glutamate transporter EAAT2 and its implications in neurological disorders and manganese toxicityPharmacogenetic Analysis of Functional Glutamate System Gene Variants and Clinical Response to Clozapine.Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons.GC-binding factor 2 interacts with dishevelled and regulates Wnt signaling pathways in human carcinoma cell lines.Characterization of LRRFIP1.Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice.Amelioration of ischemic brain damage by peritoneal dialysis.A polymorphism in the promoter region of the survivin gene is related to hemorrhagic transformation in patients with acute ischemic stroke.Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro.Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.Variants of the EAAT2 Glutamate Transporter Gene Promoter Are Associated with Cerebral Palsy in Preterm Infants.Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection.Influence of an interaction between lithium salts and a functional polymorphism in SLC1A2 on the history of illness in bipolar disorder.Structure-Function Relationship of Transporters in the Glutamate-Glutamine Cycle of the Central Nervous System.
P2860
Q24671657-5AF1D995-9DF2-4514-98F0-C1A322A9E429Q26775633-D348C205-DECF-42E5-903E-2F6DB1A38FE8Q28547044-EC223801-F3E7-4083-96F9-909AEE1B78B3Q30410519-D8DA92B7-C538-439E-9890-4F2ABCB75789Q33468639-2E65E47E-3F9F-4CA1-92F0-F97776681484Q33870421-9B369FE8-5BC6-4C05-A970-83AD658647A6Q33959301-310EEE71-F2E3-42FE-BA7A-42568B15477BQ35028072-A748BB94-1A14-45E0-B85C-A631AFF432F5Q35087565-555C1606-CD10-46D6-BB86-86556B0E1D32Q35539662-218792D7-353C-4C67-BB48-AAF54C1A3A15Q35657864-23DAE01C-0D05-4A20-8B70-15FB161F4DDFQ36052481-F5AFD354-0038-48A4-8540-36613EAD7C14Q36137988-3F850999-9F7E-4B9E-A010-C6AB96DE6292Q36509851-BDEA99ED-81B0-49E5-89CF-F1BEA5C887C1Q36656439-88926286-1A0B-4B67-8EA5-2F46F2AEDCEFQ36745208-22642209-C2B8-445B-A93B-34ADD200EF12Q36808464-0FD4DFFC-E606-4AD5-8173-D236E014BB85Q36965275-EC93376B-0A62-489E-9DBD-2AFC7A33AFB4Q37329730-3EF09293-FC31-4B5E-A174-7EF0612D389DQ37678047-0E06914F-4F00-41F1-B3A4-FB6DAF0F5862Q38234167-589FC03C-1B59-4C7A-B794-DCAEFB611562Q38917991-98C1E903-8C6C-4169-88A9-6609A9D152D5Q39367072-A21EF25F-D07A-4821-A126-E76600E2AC3BQ39622579-ECEA6DBE-C538-43FA-AF1A-085745197904Q39628455-DE71753A-FE6C-4A21-AD82-FDF2FABA5136Q40179990-7F0EF346-DA76-49DA-BE36-B01194383763Q41905922-0B23634F-CB21-4816-8F97-6F1E7C8386A6Q44493252-D4BBF563-CF03-4406-9311-29650372E82FQ46225287-78B14B60-F776-433E-89BD-0487B717A461Q47211013-DC65E0F3-F0ED-489E-993E-3683D5F1478DQ48151974-1AF8BF54-8A6B-499C-9AD0-171E2D75ED43Q48314707-C53CA38D-2997-4DCA-B3FE-F94FD34BA5CDQ48356710-3B98D640-E0E1-4D87-BB56-B56D9C1F10F9Q55291849-AA49CD88-DBC2-4C92-8538-6CF13B9058AB
P2860
A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
A polymorphism in the EAAT2 pr ...... equency of progressing stroke.
@ast
A polymorphism in the EAAT2 pr ...... equency of progressing stroke.
@en
type
label
A polymorphism in the EAAT2 pr ...... equency of progressing stroke.
@ast
A polymorphism in the EAAT2 pr ...... equency of progressing stroke.
@en
prefLabel
A polymorphism in the EAAT2 pr ...... equency of progressing stroke.
@ast
A polymorphism in the EAAT2 pr ...... equency of progressing stroke.
@en
P2093
P2860
P356
P1476
A polymorphism in the EAAT2 pr ...... equency of progressing stroke.
@en
P2093
Antoni Dávalos
Ignacio Lizasoain
Joaquín Serena
José Castillo
José Vivancos
Judith Mallolas
Mar Castellanos
María A Moro
Miguel Blanco
Olivia Hurtado
P2860
P304
P356
10.1084/JEM.20051979
P407
P577
2006-03-06T00:00:00Z